Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02161718 Completed - Schizophrenia Clinical Trials

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

Start date: May 2014
Phase: Phase 2
Study type: Interventional

This double-blind, randomized study will evaluate the efficacy, safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD).

NCT ID: NCT02160886 Completed - Clinical trials for Autism Spectrum Disorder

Effects of a Task Oriented Intervention With Two Goal-setting Approaches

Start date: October 2011
Phase: N/A
Study type: Interventional

A randomized trial investigating if effects of a goal-directed task oriented intervention is influenced by who takes the decision and establishes the goal (the child or the parent) and whether establishing a goal per se influence performance and goal-achievement. The main hypothesis are that children's participation in the goal-setting process would positively influence goal achievement, children's self-identified goals would be achievable and that both groups would achieve goals that were the target of a goal-directed intervention.

NCT ID: NCT02160249 Completed - Schizophrenia Clinical Trials

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

RISE
Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether community-based rehabilitation plus facility-based care is superior to facility-based care alone in reducing disability related to schizophrenia in rural Ethiopia.

NCT ID: NCT02158546 Completed - Clinical trials for Major Depressive Disorder

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

Start date: May 2014
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of ALKS 5461.

NCT ID: NCT02158533 Completed - Clinical trials for Major Depressive Disorder

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

Start date: May 2014
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of ALKS 5461.

NCT ID: NCT02156128 Completed - Chronic Pain Clinical Trials

Subjective Memory Complaints, Objective Memory Performance and Cognitive Training

Start date: October 2013
Phase: N/A
Study type: Interventional

The aim of this study is to examine if repetitive computerized cognitive training improves working memory in patients who are on sick leave due to complex symptom disorders (chronic pain, chronic fatigue, anxiety, depression and or sleep disorders), and whether effects of cognitive control training transfer to other tasks.

NCT ID: NCT02153502 Completed - Clinical trials for Depressive Disorder, Treatment-Resistant

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Start date: July 2014
Phase: Phase 2
Study type: Interventional

The objectives of this 10-week study are to evaluate the efficacy, safety, and tolerability of AVP 786 as an adjunctive therapy compared with placebo in patients with major depressive disorder (MDD) who have shown an inadequate response to standard antidepressant treatment. A secondary objective of this study is to assess the pharmacokinetics (PK) of AVP-786 and potential correlations with pharmacodynamic effects.

NCT ID: NCT02153203 Completed - Clinical trials for Child Development Disorders, Pervasive

Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders

Start date: October 2014
Phase: N/A
Study type: Interventional

Children with autism spectrum disorders often engage in problem behaviors such as self-injury, destruction, aggression, and stereotypy. Prior research has clearly shown that these problem behaviors may interfere with learning, daily functioning, and social participation. As such, engaging in problem behaviors has a negative impact on the health and quality of life of children with autism spectrum disorders and their families. One promising solution to reduce problem behaviors in this population is the Prevent-Teach-Reinforce (PTR) model, which relies on the evidence-based practices of positive behavior support. Although the use of PTR has been gaining considerably support in schools, the model has never been evaluated as part of a rigorous large-scale study using parents as interventionists. Thus, the purpose of the project is to conduct an assessment of the effectiveness of a home-based version of the PTR model in reducing problem behaviors in children with autism spectrum disorders and in improving families' quality of life. Our hypotheses are that implementing the PTR will (a) produce larger reductions in problem behaviors than participating in an individual parent training session, (b) increase engagement in prosocial behaviors, (c) decrease parental stress, and (c) improve the quality of life of the family. The results of the study will allow an examination of whether PTR is an effective and acceptable model to reduce problem behaviors at home in this population. Given that problem behaviors incur high societal costs when they persist into adolescence and adulthood, the study may potentially lead to large cost reductions in the treatment of difficulties associated with autism spectrum disorders. By reducing engagement in problem behaviors, the implementation of the model may also promote and facilitate the social participation as well as improve the quality of life and health of children with autism spectrum disorders and their families.

NCT ID: NCT02151162 Completed - Anxiety Disorders Clinical Trials

Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses

HNP
Start date: June 11, 2014
Phase: N/A
Study type: Interventional

The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based stress management program to maintain healthy mental state in hospital nurses. The participants will be junior nurses who work in inpatient wards and are not clinically depressed. The participants will be randomly allocated to four intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids pills ; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty participants will be allocated to each arm. These interventions will terminate until three months from registration for each participant. Information about depression and anxiety symptoms (primary outcome), insomnia, burnout, presenteeism, quality of life, sick leave, consultation about mental state of herself, and oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months from registration for each participant.

NCT ID: NCT02150681 Completed - Clinical trials for Major Depressive Disorder

Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders

MBCT
Start date: October 2012
Phase: Phase 1
Study type: Interventional

This study will investigate the effectiveness of mindfulness-based cognitive therapy (MBCT) for mood stabilization in perinatal women (preconception, pregnant, and postpartum) with a history of mood disorders. MBCT is a short-term group psychotherapy that has shown effectiveness in preventing depressive relapse. MBCT teaches mindfulness practices and cognitive-behavioral techniques.